Status Approved
First Submitted Date
2016/09/06
Registered Date
2016/10/21
Last Updated Date
2016/10/12
CRIS Required
WHO ICTRP (International Clinical Trial Registry Platform) Required
1. Background
CRIS Registration Number |
KCT0002117 |
---|---|
Unique Protocol ID | KOMCIRB-160321-HR-012 |
Public/Brief Title | Comparison of the effectiveness between TENS(Transcutaneous electrical nerve stimulation), manual acupuncture, and electroacupuncture on patients with tinnitus : pilot study |
Scientific Title | Comparison of the effectiveness between TENS(Transcutaneous electrical nerve stimulation), manual acupuncture, and electroacupuncture on patients with tinnitus : pilot study |
Acronym | |
MFDS Regulated Study | No |
IND/IDE Protocol | No |
Registered at Other Registry | No |
Healthcare Benefit Approval Status |
2. Institutional Review Board / Ethics Committee
Board Approval Status | Submitted approval |
---|---|
Board Approval Number | KOMCIRB-160321-HR-012 |
Approval Date | 2016-05-13 |
Institutional Review Board Name | KYUNG HEE UNIVERSITY KOREAN MEDICINE HOSPITAL INSTITUTIONAL REVIEW BOARD |
Institutional Review Board Address | |
Institutional Review Board Telephone | |
Data Monitoring Committee | No |
3. Contact Details
Contact Person for Principal Investigator / Scientific Queries | |
---|---|
Name | HAE JUNG NAM |
Title | Associate Professor |
Telephone | +82-2-958-9244 |
Affiliation | Kyung Hee University |
Address | 26, Kyungheedae-ro, Dongdaemun-gu, Seoul, Korea |
Contact Person for Public Queries | |
Name | YOUNG KYUN MOON |
Title | Resident |
Telephone | +82-2-958-9181 |
Affiliation | Kyung Hee University Oriental Medical Center |
Address | 23, Kyungheedae-ro, Dongdaemun-gu, Seoul, Korea |
Contact Person for Updating Information | |
Name | YOUNG KYUN MOON |
Title | Resident |
Telephone | +82-2-958-9181 |
Affiliation | Kyung Hee University Oriental Medical Center |
Address | 23, Kyungheedae-ro, Dongdaemun-gu, Seoul, Korea |
4. Status
Study Site | Single | |
---|---|---|
Overall Recruitment Status | Recruiting | |
Date of First Enrollment | 2016-07-14 Actual | |
Target Number of Participant | 45 | |
Primary Completion Date | 2017-06-30 , Anticipated | |
Study Completion Date | 2017-06-30 , Anticipated | |
Recruitment Status by Participating Study Site 1 | ||
Name of Study | Kyung Hee University Oriental Medical Center | |
Recruitment Status | Recruiting | |
Date of First Enrollment | 2016-07-14 , |
5. Source of Monetary / Material Support
1. Source of Monetary/Material Support | |
---|---|
Organization Name | Kyung Hee University Oriental Medical Center |
Organization Type | Medical Institute |
Project ID |
6. Sponsor Organization
1. Sponsor Organization | |
---|---|
Organization Name | Kyung Hee University Oriental Medical Center |
Organization Type | Medical Institute |
7. Study Summary
Lay Summary | 1. Objective - The purpose of this study is to compare the effects of transcutaneous electric nerve stimulation (TENS), manual acupuncture (MA), and electroacupuncture (EA) on tinnitus. 2. Background - Electrical stimulation treatments that have been utilized to treat tinnitus are TENS, TMS(transcranial magnetic stimulation), tDCS(transcranial direct current stimulation), subcutaneous occipital nerve stimulation, DBS(Deep Brain Stimulation), and EA. Non-invasive neuromodulations are TENS, TMS, tDCS, and so on. Due to the cost-effectiveness and safety of the treatment, TENS has been used for treating tinnitus since the 1970s. In studies that have utilized TENS in the treatment of tinnitus, electrode attachment sites were varied by temporomandibular joint (TMJ), pinna, tragus, and C2 dermatome (mastoid process). The response rate of patients treated with TENS varied greatly from 17.9% to 82% depending on the study. Among them, TENS on C2 dermatome is known to exhibit an inhibitory effect on tinnitus by increasing the effect of dorsal cochlear nucleus (DCN) in the central auditory nervous system. Acupuncture is a type of traditional Korean Medicne treatment that has been used since long ago for treating tinnitus. Although its mechanism is complex, it is believed that acupuncture improves certain kind of tinnitus by stimulating somatosensory system. EA is a treatment using acupuncture needles with electrical stimulation. For this reason, it is considered to have both characteristics of manual acupuncture and electrical stimulation therapy. Wang et al. reported a significant improvement of subjective tinnitus symptom in the EA group compared to the manual acupuncture group shortly after 6 weeks of treatment. However, the furthur study is necessay since the studies on the effects of EA for tinnitus are scarce. This study was designed to compare the effectiveness of TENS, EA, and acupuncture. The results of this study will help to determine the first line treatment of tinnitus. 3. Clinical research plan - 45 patients who meet the inclusion criteria and none of exclusion criteria after screening are randomly assigned to TENS group, EA group, and MA group, respectively by 15. Afterwards, patients will be treated twice a week for five weeks. A follow-up will be conducted four weeks after the end of treatment. Subjective tinnitus loudness and annoyance perception wil be graded using VAS every visit. THI, HRV(Heart Rate Variability), skin conductance and audiometric test will be performed at visit1, 5, 10, and follow-up session. TENS treatment will be performed by using SSP (Silver Spike Point, low frequency electrotherapeutic device – Pointron 801). A pair of electrodes are attached to the sternomastoid and lower mastoid process (C2) on the affected side, and another pair of electrodes was placed to a trigger point of masseter muscle and temporomandibular joint in front of the ear. Afterwards, 30Hz electrical stimulation was applied for 20 minutes. Patients who are assigned as manual acupuncture(MA) group and electroacupuncture(EA) group will receive acupuncture at 11 acupoints(TE21, SI19, GB2, TE22, ST7, TE17, GB20 of affected side, and GB20, TE05, KI3 of both sides) using sterilized disposable stainless needle of 0.25mm diameter and 40mm in length. Needling depth is approximately 5~10mm, it might depend on the differences of anatomical structure and individual characteristics of acupoints. Neddles will be retained for 20 minutes. EA group pateints will receive electrical stimulation at TE21, SI19 and TE17, GB20 of afftected side of tinnitus at mixed frequency 30/90Hz interval 3sec after the needles are inserted into acupoints. Both The stimulation intensity will be adjusted to relatively high but neither unpleasant nor painful level. |
---|
8. Study Design
Study Type | Interventional Study |
---|---|
Study Purpose | Treatment |
Phase | Not applicable |
Intervention Model | Parallel |
Blinding/Masking | Open |
Allocation | RCT |
Intervention Type | Medical Device |
Intervention Description | TENS treatment will be performed by using SSP (Silver Spike Point, low frequency electrotherapeutic device – Pointron 801). A pair of electrodes are attached to the sternomastoid and lower mastoid process (C2) on the affected side, and another pair of electrodes was placed to a trigger point of masseter muscle and temporomandibular joint in front of the ear. Afterwards, 30Hz electrical stimulation was applied for 20 minutes. The stimulation will be adjusted as relatively high intensity but neither unpleasant nor painful. Patients who are assigned as manual acupuncture(MA) group and electroacupuncture(EA) group will receive acupuncture at 11 acupoints(TE21, SI19, GB2, TE22, ST7, TE17, GB20 of affected side, and GB20, TE05, KI3 of both sides) using sterilized disposable stainless needle of 0.25mm diameter and 40mm in length. Needling depth will be approximately 5~10mm, depending on the differences of anatomical structure and individual characteristics of acupoints. It is advisable to retain the needles for 20 minutes. In the case of EA group, after the needles are inserted into acupoints metioned above, will receive electrical stimulation at TE21, SI19 and TE17, GB20 of afftected side of tinnitus at mixed frequency 30/90Hz interval 3sec. Stimulation intensity needs to be relatively high but neither unpleasant nor painful. |
Number of Arms | 3 |
Arm 1 |
Arm Label TENS(Transcutaneous Electrical Nerve Stimulation) treatment group |
Target Number of Participant 15 |
|
Arm Type Experimental |
|
Arm Description TENS treatment will be performed by using SSP (Silver Spike Point, low frequency electrotherapeutic device – Pointron 801). A pair of electrodes are attached to the sternomastoid and lower mastoid process (C2) on the affected side, and another pair of electrodes was placed to a trigger point of masseter muscle and temporomandibular joint in front of the ear. Afterwards, 30Hz electrical stimulation was applied for 20 minutes. The stimulus intensity needed to be relatively high but neither unpleasant nor painful. |
|
Arm 2 |
Arm Label Manual Acupuncture treatment group |
Target Number of Participant 15 |
|
Arm Type Active comparator |
|
Arm Description Patients who are assigned as manual acupuncture(MA) group and electroacupuncture(EA) group will receive acupuncture at 11 acupoints(TE21, SI19, GB2, TE22, ST7, TE17, GB20 of affected side, and GB20, TE05, KI3 of both sides) using sterilized disposable stainless needle of 0.25mm diameter and 40mm in length. Needling depth will be approximately 5~10mm, depending on the differences of anatomical structure and individual characteristics of acupoints. Acupuncture needles will be retained for 20 minutes. |
|
Arm 3 |
Arm Label Electroacupuncture treatment group |
Target Number of Participant 15 |
|
Arm Type Active comparator |
|
Arm Description After the needles are inserted into acupoints metioned above, will receive electrical stimulation at TE21, SI19 and TE17, GB20 of afftected side of tinnitus at mixed frequency 30/90Hz interval 3sec. Stimulation intensity will be relatively high but neither unpleasant nor painful. |
9. Subject Eligibility
Condition(s)/Problem(s) |
* (H60-H95)Diseases of the ear and mastoid process (H93.1)Tinnitus |
---|---|
Rare Disease | No |
Inclusion Criteria |
Gender Both |
Age 20Year~75Year |
|
Description 1. Men and women aged 20 to 75 2. Patients with persistent tinnitus for 6 months or more 3. Patients who have agreed not to receive any type of medical treatment from another hospital to treat tinnitus 4. Patients who voluntarily choose to participate in the study |
|
Exclusion Criteria |
1. Patients who have undergone tinnitus treatment such as acupuncture and TENS within three months 2. Patients who have medicines and surgical procedures due to cardiac disorder, or patients with pacemaker implants 3. Patients with disease—meniere’s disease, tympanitis, and otosclerosis—that certainly can cause tinnitus 4. Patients who have metal allergies and needle phobia 5. Patients who take psychoactive drugs to treat tinnitus symptoms 6. Patients who gave birth within six months, or patients who are currently pregnant or breastfeeding 7. Patients who are unable to perform evaluation test and complete the questionnaire 8. Patients who are considered unsuitable for the study based on the opinion of the investigators |
Healthy Volunteers |
10. Outcome Measure(s)
Type of Primary Outcome | Efficacy | |
---|---|---|
Primary Outcome(s) 1 | ||
Outcome | respond rate of Tinnitus Handicap Inventory(THI) - evaluated as a responder if THI score improved more than 10 points |
|
Timepoint | Baseline, visit 5, end of treatments(visit 10), follow-up visit(visit11, 4 weeks after the end of treatment sessions) |
|
Secondary Outcome(s) 1 | ||
Outcome | THI score |
|
Timepoint | Baseline, visit 5, end of treatments(visit 10), follow-up visit(visit11, 4 weeks after the end of treatment sessions) |
|
Secondary Outcome(s) 2 | ||
Outcome | VAS(loudness, annoyance) |
|
Timepoint | VAS : every visit (before and after the treatment in the treatment visits) |
|
Secondary Outcome(s) 3 | ||
Outcome | Pure tone audiometry(PTA) |
|
Timepoint | Baseline, visit 5, end of treatments(visit 10), follow-up visit(visit11, 4 weeks after the end of treatment sessions) |
|
Secondary Outcome(s) 4 | ||
Outcome | Speech Discrimination(SD) |
|
Timepoint | Baseline, visit 5, end of treatments(visit 10), follow-up visit(visit11, 4 weeks after the end of treatment sessions) |
|
Secondary Outcome(s) 5 | ||
Outcome | skin conductance |
|
Timepoint | Baseline, visit 5, end of treatments(visit 10) |
|
Secondary Outcome(s) 6 | ||
Outcome | Heart Rate Variability(HRV) |
|
Timepoint | Baseline, visit 5, end of treatments(visit 10) |
11. Study Results and Publication
Result Registered |
---|
12. Sharing of Study Data(Deidentified Individual-Patient Data, IPD)
Sharing Statement | Not provided at time of Registration |
---|
TOP
BOTTOM
화면 최하단으로 이동